A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Each batch carries a unique COA
That gap between expectation and reality is worth understanding, because it points to something important about how mood act
Consider Musely, a company that sells skin cream for dark spots
It solved the problem I had with reagent degradation, allowing for more consistent results across my experiments
This technology-driven recovery session boosts circulation, relieves tension, reduces soreness, and helps your body reset faster perfect for athletes, busy professionals, and anyone who wants to feel lighter, looser, and fully restored
